Flash Technology Prevents Pain From Carpal Tunnel Syndrome
... Tunnel Syndrome. It also offers a series of free exercises which can be done during a short break at the ... or eliminating wrist pain. The 5-7 minutes desk exercises are an application of The Anat ... animations and multimedia explanations during the exercises allow users to be aware of the changes that ...NeurogesX Reports Second Quarter 2009 Results
... efforts for this program. The decision to license NGX-1998 by Astellas is subject to their option right under the agreement. If Astellas retains and exercises such option right, they would be required to pay further payments to NeurogesX. In addition, if such option is exercised, the companies would ...Pharmacyclics Announces Subscription Price for Rights Offering
... Shares of the Company's common stock that are not subscribed for under the basic subscription rights will be offered to each rights holder that exercises its basic subscription rights in full at the same purchase price per share, as provided in the prospectus. Rights offering materials, ...Platoon Fitness Announces Platoon University
... in its outdoor training methods. Trainers will travel to Bryn Mawr to learn exciting new techniques in the realm of outdoor fitness. Over 1100 exercises will be taught to Platoon U participants hoping to be certified in this exciting addition to the fitness world. During the last day of the ...Pharmacyclics Files Registration Statement for Rights Offering
... all existing indebtedness of the company. The rights offering includes an oversubscription privilege which permits each rights holder that exercises its rights in full to purchase additional shares of common stock that remain unsubscribed at the expiration of the offering. This oversubscription ...BioSpecifics Technologies Corp. Reports First Quarter 2009 Financial Results
... sublicense income payments we may receive; the amount of earn out payments we may receive from DFB Biotech Inc. and its affiliates; whether Auxilium exercises its option under our license agreement for additional indications; the potential benefits of our existing license and development agreements; our ...BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results
... sublicense income payments we may receive; the amount of earn out payments we may receive from DFB Biotech Inc. and its affiliates; whether Auxilium exercises its option under our license agreement for additional indications; the potential benefits of our existing license and development agreements; our ...EPA Presents Initial Results from Caliper Life Sciences' ToxCast Screening Effort
... - EPA exercises Option to Extend Contract with Caliper - HOPKINTON, Mass., March 19 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ), a ...Martek Announces First Quarter 2009 Financial Results
... of notes payable and other long-term obligations, net (29) (252) Proceeds from stock option exercises and other, net 82 4,123 Net cash provided by financing activities ...Dr. Peper, Dr. Freud and Arnold Schwarzenegger
... BCIA Didactic Biofeedback Education requirements through powerful demonstrations of biofeedback and adjunctive procedures, imaginative hands-on lab exercises with multi-channel computerized equipment, professional multimedia presentations, and comprehensive review materials. To register visit ...Cephalon's New Product Launches Pace Record 2008 Sales
... (172,946) -------- -------- CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from exercises of common stock options 43,962 93,900 Windfall tax benefits from stock-based ...Martek Announces Fourth Quarter and FY 2008 Financial Results
... (8,917) (1,013) Repayments under revolving credit facility, net - (36,000) Proceeds from stock option exercises and other, net 10,021 3,272 Net cash provided by (used in) financing activities 1,104 (33,741) Net change in cash, cash ...Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
... antibody for AD. The drug is currently being tested in humans. We are entitled to an upfront payment if and when this pharmaceutical company exercises the option in the first quarter of 2009 as well as patent milestones and royalties from sales. We are in discussions to grant additional licenses to ...ev3 Inc. Reports Third Quarter 2008 Financial Results
... titled non-GAAP financial measures differently than ev3, limiting the usefulness of those measures for comparative purposes. -- ev3's management exercises judgment in determining which types of charges or other items should be excluded from the non-GAAP financial measures ev3 uses. ev3 compensates for ...Cephalon Reports Another Strong Quarter
... for investing activities (79,910) (200,934) CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from exercises of common stock options 37,185 74,375 Windfall tax benefits from stock-based compensation ...Brain Fitness Program Offers Hope for Breast Cancer Survivors Suffering From 'Chemobrain'
... symptoms. The program, which is widely regarded as a breakthrough by the medical community, is a series of 6, specially engineered, computer based exercises designed by neuroscientists. The results presented by lead Investigator, Sarah-Jane Kim, MA, show that cognitive training on the Posit Science ...KGI Offers Mammalian Cell Culture Program for Biotech Industry Professionals
... and operation of high density fed-batch cultures in large-scale bioreactors. In keeping with KGI's hands-on learning philosophy, the laboratory exercises will provide experience with many of the techniques and principles taught in that day's lectures. Course attendees will gain first-hand experience in ...Martek Announces Third Quarter 2008 Financial Results
... (8,888) (759) Repayments under revolving credit facility, net - (19,000) Proceeds from stock option exercises and other, net 7,243 2,209 Net cash used in financing activities (1,645) ...FDA Gets Knocked Out in Endotec, Inc. Ruling
... were custom-made medical devices exempt from FDA regulation. Eight years after his ankle replacement surgery, Vincent has no restrictions. He exercises regularly three-days a week, rides a stationary bike, lifts weights, hikes over mountain roads, traverses trout streams, and rides his 15-speed bike ...AtriCure Reports Record Second Quarter 2008 Financial Results
... Cash flows from financing activities: Payments on debt and capital leases (221,139) (191,798) Proceeds from stock option exercises 174,122 151,345 Gross proceeds from sale of stock - 16,499,997 Net cash (used in) provided by ...Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008
... 18,040 Net cash used for investing activities (67,119) (19,952) CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from exercises of common stock options 13,562 66,205 Windfall tax benefits from stock-based compensation ...Martek Announces Second Quarter 2008 Financial Results
... (426) (505) Repayments under revolving credit facility, net - (5,000) Proceeds from stock option exercises and other, net 5,944 1,903 Net cash provided by (used in) financing activities ...InterCure Supports AHA Endorsement of Home Blood Pressure Monitoring
... interactively guiding the user to effortlessly reduce their breathing rate to a "therapeutic zone" of less than 10 breaths per minute. The breathing exercises with RESPeRATE relax the constricted muscles surrounding the small blood vessels, allowing the blood to flow more freely and yielding a significant ...E. coli Outbreak in New Jersey?
... tested our ability to recognize a potential outbreak, but also our capability to manage an unusually large influx of potentially infectious patients. exercises of this nature are performed every year at hospitals and medical facilities throughout the country in accordance with Joint Commission standards. ...AtriCure Reports First Quarter 2008 Financial Results
... on long-term debt and capital lease obligations (523,063) (94,936) Proceeds from stock option exercises 111,699 126,241 Net cash (used in) provided by financing activities (411,364) ...Beckman Coulter Announces First Quarter 2008 Results
... doubtful accounts receivable 1.0 2.0 Share-based compensation expense 9.5 6.1 Tax benefits from exercises of share-based payment awards 2.3 9.4 Excess tax benefits from share-based payment transactions ...Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance
... cash used for investing activities (172,946) (20,376) CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from exercises of common stock options 93,900 143,491 Windfall tax benefits from stock-based compensation ...Martek Announces Fourth Quarter and FY 2007 Financial Results
... Repayments under revolving credit facility, net (36,000) (19,000) Proceeds from stock option exercises and other, net 3,272 4,509 Net cash used in financing activities (33,741) ...NEWSWEEK: Media Lead Sheet/December 10, 2007 Issue (on newsstands Monday, December 3).
... into the workings of how the mind creates and stores memories to better understand age-related declines in retention as well as developing drugs and exercises that help push your aging brain to recall more. http://www.newsweek.com/id/73356 "Bones of Invention" (p. 88). Contributing Editor Barbara ...Cephalon Announces Strong Third Quarter Financial Results
... by (used for) investing activities (200,934) 30,538 CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from exercises of common stock options 74,375 112,794 Windfall tax benefits from stock-based compensation ...Beckman Coulter Announces Third Quarter 2007 Results
... doubtful accounts receivable 4.1 5.0 Share-based compensation expense 19.9 21.4 Tax benefits from exercises of share-based payment awards 20.2 5.1 Excess tax benefits from share-based payment ...InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom
... interactively guiding the user to effortlessly reduce their breathing rate to a "therapeutic zone" of less than 10 breaths per minute. The breathing exercises with RESPeRATE relax the constricted muscles surrounding the small blood vessels, allowing the blood to flow more freely and yielding a significant ...Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis
... agreement, the MPM Bio IV NVS Strategic Fund L.P. has purchased $10 million of Series C preferred stock of Radius. In the event that Novartis exercises the option to license BA058, Novartis would assume the global clinical development, manufacturing, and marketing of BA058 and all associated costs. ...